Nimotuzumab abrogates acquired radioresistance of KYSE-150R esophageal cancer cells by inhibiting EGFR signaling and cellular DNA repair

Nimotuzumab abrogates acquired radioresistance of KYSE-150R esophageal cancer cells by inhibiting EGFR signaling and cellular DNA repair

Hai Liu,1 Weifang Yang,2 Huaping Gao,3 Tingting Jiang,1 Bengxin Gu,1 Qinghua Dong,4 Wenhong Xu,5 Shixiu Wu,6 Xiaonan Sun1 1Department of Radiation Oncology, Sir Run Run Shaw Hospital, Sir Run Run Shaw Institute of Clinical Medicine of Zhejiang University, Hangzhou, People’s Republic of C...

Full description

Bibliographic Details
Main Authors: Liu H, Yang W, Gao H, Jiang T, Gu B, Dong Q, Xu W, Wu S, Sun X
Format: Article
Language:English
Published: Dove Medical Press 2015-02-01
Series:OncoTargets and Therapy
Online Access:http://www.dovepress.com/nimotuzumab-abrogates-acquired-radioresistance-of-kyse-150r-esophageal-peer-reviewed-article-OTT

Internet

http://www.dovepress.com/nimotuzumab-abrogates-acquired-radioresistance-of-kyse-150r-esophageal-peer-reviewed-article-OTT

Similar Items